1. Introduction {#S1}
===============

*Bordetella pertussis* (*Bp*) is the etiologic agent of pertussis or whooping cough, a highly contagious respiratory disease occurring primarily in infants and young children ([@R5]; [@R36]). Current vaccines used in the United States are acellular. They consist of three to five *Bp* proteins ([@R28]; [@R38]), including filamentous hemagglutinin adhesin (FHA), pertactin (Prn), pertussis toxin (Ptx), and fimbrae 2 and 3. These latter proteins are purified from *Bp* strains isolated from the 1940s and 1950s. Many countries throughout the world, however, continue to use whole-cell vaccines. Although pertussis is a vaccine-preventable disease, the World Health Organization (WHO) estimates that 30--50 million cases per year occur worldwide, with approximately 300,000 deaths ([@R17]). In fact, pertussis cases have increased over the years, leading researchers to reevaluate vaccine control strategies. This resurgence in pertussis cases has occurred globally ([@R21]; [@R9]) and has occurred in populations or areas previously immunoprotected by vaccination. Although the cause for the observed increased disease incidence is not fully understood, possible contributing factors are better diagnostics and surveillance, waning vaccine-induced immunity, suboptimal vaccine formulation, and variation between circulating isolates and vaccine strains ([@R16]; [@R29]; [@R3]) which are all currently under investigation.

With the sequencing of many microbial pathogen genomes complete ([@R34]) or underway, many researchers have relied on functional genomics to translate the genetic "blueprint" of an organism and to understand biological processes. But with constantly advancing methods and technologies, the use of proteomic-based strategies has emerged as an option to study cellular function. In general, proteomics revolutionized in the mid 1970s ([@R32]; [@R44]) is the analysis of an organism\'s proteome or, in essence, its complete array of expressed genes or proteins.

Traditional proteomic approaches, such as one- (1D) or two-dimensional (2D) gel electrophoresis (GE), are common technologies to visualize and separate proteins based on molecular weight and/or isolectric point (pI). 1D and 2D-GE, albeit fruitful, can be labor intensive and not without technical challenges. For instance, 1D-GE cannot sufficiently resolve very large proteins or complexes that generally are membrane-affiliated and hydrophobic in nature. Also, small proteins often expressed in low abundance may escape visual detection dependent upon the rate of gel migration ([@R23]). However, to overcome these limitations subcellular compartments, such as outer membrane proteins (OMPs) or surfaceomes can be isolated by physical or chemical means, and further enriched using sodium carbonate ([@R40]) followed by differential centrifugation. Fractionation reduces sample complexity and promotes further examination by GE or mass spectrometry (MS). Nano liquid chromatography-electrospray ionization tandem MS (nLC-ESI MS/MS) is a powerful and sensitive analytical tool used to further elucidate and characterize proteins in complex mixtures ([@R11]; [@R14]). Proteins can be proteolytically cleaved by enzymes such as trypsin, generating peptides that are first separated by differential retention on the LC column then ionized and separated based on their mass-to-charge ratio (m/z). The proteins from which they originate are identified based on the comparison between MS/MS fragmentation patterns and protein databases ([@R7]).

Over the years, gel-based strategies in parallel with MS have been used with great success in the characterization of bacterial surfaceomes (surface membrane fraction). For example, [@R37] performed a comparative surfaceome analysis of pathogenic enterotoxigenic *Escherichia coli* (ETEC) and commensal strains using gel and MS-based proteomic approaches. In addition, nLC-ESI MS/MS analysis was used to profile the surfaceome of four genetically distinct *Staphylococcus aureus* strains ([@R10]). [@R40] evaluated the efficiency of multiple surfaceome isolations using nLC-ESI MS/MS, GE, and immunoblotting methodologies for OMP identification of various gram negative bacteria, including *Pseudomonas aeruginosa*. And [@R19] performed a high-throughput proteomics study using nLC-ESI MS/MS to identify cellular proteins from pathogenic *E. coli* 0157:H7 and *Yersinia pestis*. Lastly, [@R6] described a procedure for the enrichment of *Bp* outer membrane proteins (OMPs) followed by protein identification using GE-associated mass spectrometric technologies and database search analysis as the basis for novel pertussis vaccine development.

*Bp*, a gram-negative organism, contains outer and cytoplasmic (or inner) membranes separated by a periplasmic space. Proteins embedded within the membrane and surface-exposed are of biological importance. These bacterial proteins act as front-line barriers to the hosts\' antibody-mediated cellular environment. They contain possible virulence factors, and they play a role in the attachment to host cells as well as in the transport of nutrients into the bacteria needed for growth and survival ([@R35]; [@R42]; [@R23]; [@R25]). Thus, further examination of this subproteome (in particular for clinical pathogens) by GE or advanced technologies such as MS, would be fruitful for the development of novel diagnostics, strain comparison, or potentially for improved vaccine development.

In this study, a comparative qualitative proteomic assessment of three clinical *Bp* strains isolated in the United States and the well-typed acellular and whole-cell vaccine strain Tohama I was investigated. Since changes in OMP expression might affect several bacterial functions such as adherence and pathogenesis with possible implications on host cellular immunity ([@R23]; [@R19]), we examined the surfaceome and immunoproteome (i.e., antigenic proteins that invoke an immune response). Protein profiles were generated using a multi-combinatorial approach of 1D-GE and/or direct nLC-ESI MS/MS tryptic peptide detection and OMP identification via database search analysis. Additionally, immunoblot-associated MS analysis and a novel approach using antibody affinity magnetic-bead-capture coupled to MS were used to identify *Bp* immunoreactive proteins. This antibody affinity, magnetic-bead-capture technique proved to be a labor-saving strategy that assisted in the quick assessment of *Bp* protein immunoreactivity. This strategy shows great promise as an expeditious approach -- applicable to a broad spectrum of organisms -- to identify surface-expressed antigens which, once detected and identified, could be used for strain comparisons and for improved diagnostics.

2. Materials and methods {#S2}
========================

[Fig. 1](#F1){ref-type="fig"} is a flow diagram schematically summating the core methodologies used in this study.

2.1. Reagents {#S3}
-------------

All reagents and media not vendor-specified were prepared at the Centers for Disease Control and Prevention (CDC) Core Facility. In addition, chemicals used in experimentation were obtained from either Sigma-Aldrich Chemical Company (St. Louis, MO, USA) or Fisher Scientific (Pittsburg, PA, USA) as noted.

2.2. Bacterial strains {#S4}
----------------------

Four *Bp* strains, Tohama I (T) and three clinical isolates designated by CDC as C056 (C), D946 (D) and F656 (F) were used in the proteomic comparison ([Table 1](#T1){ref-type="table"}). T, first isolated in Japan in 1954, is a well-characterized and completely sequenced *Bp* strain that has been used as the basis of vaccines in many countries for several years ([@R1]). By pulse-field gel electrophoresis (PFGE) analysis, it is characterized as type II and possesses the pertactin 1 (*prnA1*) and pertussis toxin (*ptxS1B*) genotype typical of prevaccine-era isolates ([@R1]; [@R43]; [@R27]). Strain C was isolated in Minnesota in 1998, has a PFGE CDC type 10 ([@R15]), and a *prnA2, ptxS1A* genotype common among currently circulating isolates ([@R27]). The D strain, a clinical isolate identified in Georgia in 2002, has a PFGE CDC 21, *prnA1* and *ptxS1A* genotype. It has shown resistance to the antibiotic erythromycin. Lastly, the F strain (PFGE CDC 206, *prnA2, ptxS1A*) was isolated from a clinical case in 2007 in the Virgin Islands.

2.3. Bacterial cell culture {#S5}
---------------------------

T, C, D, and F were plated on Bordet-Gengou agar and incubated at 35 °C with 5% CO~2~ for 4 days ([@R18]). The bacteria were subsequently subcultured into Modified Stainer-Schulte (MSS) media at 35 °C, with aeration at 200 rpm in a Beckman-Coulter shaker (Beckman-Coulter, Brea, CA, USA) until an optical 1.0 density was reached. The bacterial strains were then pelleted from MSS by centrifugation at 8000×*g* for 30 min (min) at 4 °C. The pellets were washed two times in distilled water (dH~2~O) and stored at −70 °C for further use.

2.4. Enriched membrane fraction collection {#S6}
------------------------------------------

Enriched membrane fractions (EMFs) were collected as previously described ([@R30]) with the following modifications. Briefly, cell pellets of *Bp* isolates were allowed to thaw gently on ice. The pellets were French-pressed at 16,000 psi in 5 ml of a 50-mM Tris--HCl (pH 8.0) buffer containing a protease inhibitor cocktail added at the manufacturer\'s recommendation (GE Healthcare, Piscataway, NJ, USA), and 25U of benzonase to rupture bacterial cells. The lysates were centrifuged (8000×*g*, 20 min, 4 °C) to remove unbroken cells, and the supernatant containing the total extracted proteome was retained. 50 ml of ice-cold sodium carbonate (pH 11.0) was added to 5 ml of each bacterial supernatant. The mixture was stirred gently at 4 °C for 2 h. The sodium carbonate infused-supernatants were subjected to ultracentrifugation (Beckman-Coulter) (115,000×*g*, 60 min, 4 °C) to enrich for a membrane protein fraction. The pellets containing the EMFs were washed in a 50 mM Tris--HCl buffer (pH 8.0) and ultracentrifuged twice (115,000×*g*, 30 min, 4 °C) to remove the enrichment buffer. The final EMFs were solubilized in 1 ml of solubilization buffer containing 7 M urea, 2 M thiourea, 2% CHAPS, 10% isopropanol, and protease inhibitor cocktail, with an optional addition of 0.5% bromophenol blue to visually assess the integrity of protein isolation. Protein concentrations of the samples were determined using a 2D-Quant Kit (GE Healthcare), and the samples were aliquoted and frozen at −20 °C until further use.

2.5. B. pertussis immune sera {#S7}
-----------------------------

Three-week-old female BALB/C mice were initially injected intraperitoneally (i.p.) with 1 × 10^9^ colony forming units (cfu) of T, C, D, or F suspended in 10 µl of physiological saline (pH 7.2). Before injection, strains were cobalt-irradiated using 5 × 10^6^ γ RAD to inhibit bacterial replication and infectivity, while preserving bacterial surface structures. The process was repeated 2 weeks later, every 2 weeks thereafter, with three separate i.p. immunizations of similar dosage for 6 weeks. At this time, mice were euthanized according to AALAC and IACUC standards and the *Bp* immune sera generated from each strain were collected from blood. The collected serum was aliquoted and stored at −70 °C until use. Additionally, a serum pool composed of sera drawn from convalescent pertussis human patients obtained from the CDC Pertussis Laboratory was used in this analysis. This pool is the Pertussis Laboratory ELISA standard reference sera acquired in accordance with CDC Institutional Review Board standards and regulations.

2.6. 1D sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and immunoblot analysis of B. pertussis EMF {#S8}
------------------------------------------------------------------------------------------------------------------------

Unless specified, materials, antibodies, and procedures for GE and immunoblot analysis were obtained from Bio-Rad (Hercules, CA, USA). 10 µg of total EMF proteins from each strain was suspended in Laemmli sample buffer and electrophoresed on 12.5% SDS-PAGE gels following standard protocols ([@R24]). To visualize separated proteins, gels were stained using the hot coomassie blue staining protocol. EMF proteins were electroblotted ([@R41]) onto polyvinylidene fluoride (PVDF) membranes for 1 h and probed with either a primary *Bp* strain-specific immune or preimmune (normal) mouse serum. Immunoreactive bands were further probed with a secondary goat-anti-mouse horseradish peroxidase-conjugated IgG antibody and subsequently visualized with 1,4-benzenediamine dihydrochloride (Sigma-Aldrich).

2.7. PVDF on-membrane protein extraction {#S9}
----------------------------------------

Protein extraction directly from blotted-PVDF membranes was performed based on [@R4], but modified accordingly. PVDF membrane bands containing EMF proteins from T and C associated with immunoreactivity were excised and destained with 50% methanol (500 µl) for 2 h at room temperature (RT). After destaining, the supernatant was removed. The membrane pieces were air dried, followed by the addition of 50 mM ammonium bicarbonate (NH~4~(CO~3~)~2~) digestion buffer in 30% acetonitrile (ACN) (Fisher Scientific). The protein-containing membrane pieces were then incubated overnight (ON) with trypsin (0.1 µg/µl) (Promega Corporation, Carlsbad, CA, USA) at 37 °C. After digestion, the supernatant was collected and the membranes were treated with 80% ACN to extract the peptides and sonicated at level nine (Aquasonic™ model 150-D)(VWR Scientific Products, Suwanee, GA) for 15 min. Following sonication, the extract was pooled with the previous supernatant, dried via vacuum centrifugation, and resuspended in dH~2~O (50 µl). Samples were prepared for nLC-ESI-MS/MS, in which peptides were suspended in equal volumes of 0.1% formic acid.

2.8. EMF protein identification {#S10}
-------------------------------

T, C, D, or F EMFs (10 µg) before direct proteolytic cleavage were treated with 0.1% rapigest (RG) (Waters Corporation, Milford, MA, USA) in NH~4~(CO~3~)~2~ digestion buffer at 100 °C for 5 min to denature proteins. Upon cooling at RT, the samples were incubated ON with trypsin (10 µg) (Promega) at 37 °C. After incubation, the RG was inactivated in the presence of 1 M HCl for 30 min at 37 °C, and centrifuged at 12,000×*g* for 15 min. The supernatant was removed and suspended in equal volumes of 0.1% formic acid and analyzed by nLC-ESI MS/MS. The data obtained represent two distinct biological preparations, each performed in triplicate.

2.9. Immunoprecipitation studies using antibody affinity magnetic bead capture technology {#S11}
-----------------------------------------------------------------------------------------

Dynal beads (Invitrogen Corporation, Carlsbad, CA, USA) coated with protein G for immunoglobulin (IgG) capture and subsequent immunoprecipitaton (IP) of EMFs were used as per the manufacturer\'s recommendation with the following changes. The Dynal beads (200 µl per sample) were initially washed three times via resuspension in 800 µl phosphate citrate buffer (PCB), pH 5.0 (Sigma-Aldrich). Next, the beads were resuspended in 800 µl PCB and incubated ON at 37 °C in the presence of immune sera (100 µg total) from mice immunized against T, C, D or F. We also prepared controls containing normal mouse immune sera (100 µg total) and beads only. After incubation, the beads were magnetically stabilized, the supernatant was removed, and the beads were washed two times with 2 M triethanolamine, pH 8.2 (Sigma-Aldrich). This was to remove unbound antibodies and to equilibrate the beads for antibody crosslinking. The immune-sera bound beads were next cross-linked with 1 ml 20 mM dimethyl pimelimidate (Sigma-Aldrich) in 2 M triethanolamine for 30 min at RT via inversion. Following crosslinking, the beads were washed two times in 800 µl phosphate buffer saline (PBS), pH 7.0 with 0.1% Tween 20 and further incubated with 800 µl TBE (Sigma-Aldrich) to reduce non-specific (NS) protein binding. The beads were resuspended in 50 µl dH~2~O. Then they were incubated at 37 °C ON in the presence of T, C, D or F EMFs (10 µg) that corresponded with the bead-Ab source strain (e.g., beads bound with T-specific IgG were incubated in the presence of T-EMF). After magnetic stabilization, the beads were washed via a mixer three times for 5 min with 100 µl PBS at RT to remove any unbound or NS-bound EMF proteins. The protein-bound Ab-coupled complexes were resuspended in 50 µl NH~4~(CO~3~)~2~ digestion buffer treated with 0.1% RG followed by ON trypsin (10 µg) digestion at 37 °C.

Upon incubation, the IP complex was magnetically stabilized, and the supernatant containing EMF tryptic peptides was transferred to a fresh tube and dried via vacuum centrifugation to concentrate samples. The RG was inactivated and the samples prepared for nLC-ESIMS/MS, in which peptides were suspended in equal volumes of 0.1% formic acid. The data represent two biological preparations, each performed in duplicate. Simultaneously, Dynal beads were conjugated with pooled human convalescent sera (100 µg total) resulting from *Bp* infection in addition to normal human IgG (Interstate Blood Bank, Inc., Memphis, TN, USA). The IgG bound-beads were incubated with T, C, D, or F EMF (10 µg), and the samples were processed as described above.

2.10. Nano liquid chromatography electrospray ionization mass spectrometry {#S12}
--------------------------------------------------------------------------

Protein identification was achieved by using nanoflow liquid chromatography (nano-LC), data-dependent tandem mass spectrometry, and database searching. A pulled-needle, fused silica capillary (365 µm O.D. by 75 µm I.D.) (New Objective, Inc., Woburn, MA) was packed with 10 cm of 5 µm Symmetry 300 reverse-phase packing material (Waters Inc., Bedford, MA). Protein digests were loaded onto the analytical column and separated by gradient elution using an Eksigent 2D nanoLC system (Eksigent Technologies, Inc, Dublin, CA). The mobile phase solvents consisted of (solvent A) 0.2% formic acid (Thermo Scientific, Rockford, IL), 0.005% trifluoroacetic acid (Sigma-Aldrich) in water (Burdick and Jackson, Muskegon, MI), and (solvent B) 0.2% formic acid, 0.005% trifluoroacetic acid in acetonitrile (Burdick and Jackson). The gradient flow was set at 400 nl/min. The profile consisted of a hold at 5% B for 5 min followed by a ramp to 30% B over 100 min, then a ramp up to 90% B in 5 min and a hold at 90% for 2 min before returning to 5% B in 2 min and re-equilibration at 5% B for 20 min. After chromatography, peptides were introduced into an LTQ Orbitrap tandem mass spectrometer (Thermo Scientific, San Jose, CA). A 2.0 kV voltage was applied to the nano-LC column. The mass spectrometer was programmed to perform data-dependent acquisition by scanning the mass range from mass-to-charge (m/z) 400 to 1600 at a nominal resolution setting of 60,000 for parent ion acquisition in the Orbitrap. Most tryptic peptides fall within the stated m/z range and served as the basis for this selection. For MS/MS analysis the mass spectrometer chose the top 10 most intense ions with two or more charges. Singly charged ions were rejected for MS/MS as these ions are likely due to detergents or other sample additives. In particular for a data-dependent acquisition, time is better utilized acquiring for doubly and triply charged amino acids, which predominantly have greater sequence specificity since they are larger peptides and thus provide a higher likelihood in which to uniquely identify a protein.

All tandem mass spectra were extracted from the raw data file using Mascot Distiller (Matrix Science, London, UK; version 2.2.1.0) and searched using Mascot (version 2.2.0). Mascot was set up to search using the entire NCBInr database or a modified NCBInr database created to search "*Bordetella*"- or "pertussis"- recognized proteins in which trypsin is used as the digestion agent. Mascot was searched with two missed cleavages, a fragment ion tolerance mass of 0.80 Da, and a parent ion tolerance of 200 ppm, while oxidation was selected as a variable modification. Scaffold (Proteome Software, Portland, OR) was used to validate MS/MS based peptide and protein identifications.

Peptide identifications were accepted if they could be established at greater than 95.0% probability as specified by the Peptide Prophet algorithm ([@R20]). Protein identifications were accepted if they could be established at greater than 99.0% probability and contained at least two identified peptides ([@R31]). With these stringent parameters of Peptide Prophet and Protein Prophet within the Scaffold software, the probability of a wrong assignment is below 0.1%. PSORTb subcellular scores were used to predict and localize identified EMF proteins (<http://www.psort.org/psortb/>) ([@R45]). Lastly, KEGG identifiers using NCBI Gi accession numbers were employed to assign functions to each of the identified proteins <http://www.genome.jp/kegg/kegg3.html> ([@R39]).

3. Results {#S13}
==========

3.1. 1GE and immunoblot analysis of B. pertussis species EMFs {#S14}
-------------------------------------------------------------

Carbonate-enriched EMF proteins were initially separated by 1D-SDS-PAGE (1D-GE). This was to observe common and differential banding patterns between the T-reference strain and clinical isolates C, D, and F. Overall, similar protein profiles among the strains were observed, with 1D-GE revealing slight differences and no unique protein banding patterns between the strains ([Fig. 2](#F2){ref-type="fig"}). Subsequently, after observing no major protein differences, we used classical immunoblotting approaches to assess the strain\'s ability to invoke an immune response in vivo. EMF-transferred PVDF membranes, probed with strain-specific mouse antisera, showed comparable patterns of immunoreactivity between all four strains. Likewise, the similarity in the immunoblot corresponded with the heavy banding patterns between 30 and 70 kDa observed in the stained gel (data not shown).

Collectively, the gel and immunoblot results indicate similarity in the proteins expressed among these strains. And nominal differences appeared between the immune responses seen in mice against T, C, D, and F. Nevertheless, to delineate any significant variability which was not visually observable, a few major immunoreactive protein bands from 30 to 35 and 40 to 45 kDa were analyzed for T and C. Peptides extracted from tryptically digested, excised-PVDF membranes were separated and analyzed using nLC-ESI-MS/MS. Database mining revealed a few proteins in both the T and C highly immunoreactive bands. These included a 42-kDa outer membrane porin precursor (OmpP), a 40-kDa outer membrane porin protein OmpQ (OmpQ), and a 40-kDa putative exported protein. The C-EMF-probed excised protein bands also identified a 33-kDa putative membrane protein.

3.2. Direct surfaceome analysis of Bp EMFs using nLC-ESI-MS/MS {#S15}
--------------------------------------------------------------

Although *Bp* EMF proteins were separated and visualized using GE, and a few further identified by an on-membrane analysis in combination with MS, a more direct and less time-consuming surfaceome analysis was ultimately implemented.

RG-treated and trypsinized-EMFs from the four strains were analyzed directly using nLC-ESI MS/MS. This was followed by database searching, in which 259, 249, 253, and 245 proteins were identified for T, C, D and F, respectively. However, based on greater than 95% Scaffold protein identification and amino acid coverage probabilities, 193 total proteins among all four strains were further selected ([Table 2A](#T2){ref-type="table"}). Moreover, using PSORTb subcellular localization scores, proteins considered membrane (outer, periplasmic, or cytoplasmic) or found in the cytoplasm accounted for 44% and 29%, respectively, of the total "surfaceome" identified in this study. The remaining proteins classified as "unknown" were possibly localized to the membrane or cytoplasm and comprised 27% of the total surfaceome ([Table 2B](#T2){ref-type="table"}).

In general, the identified proteins included, but were not limited to, secreted proteins and toxins, as well as outer membrane proteins affiliated with cell membrane synthesis, cellular transport, adhesion, pathogenesis, or virulence. Additionally, the EMF proteomic profiles consisted of proteins associated with protein synthesis. These included highly abundant ribosomal proteins and elongation factors, DNA synthesis-associated proteins, metabolic enzymes, and hypothetical proteins (HP) with unknown functions ([Table 2C](#T2){ref-type="table"}).

In all, we discovered 163 proteins in the EMFs of all four strains ([Table 2D](#T2){ref-type="table"}). Among them were the expected surface proteins filamentous hemagglutinin adhesin (FHA) and pertactin (Prn), OmpQ, a serum resistance protein (BrkA), a TonB-dependent receptor for iron transport (TonB), a tracheal colonization factor precursor (TcfA), 30S ribosomal proteins S2 and S3, chaperonin GroEL (GroEL), and elongation factor Tu (EF-Tu). Common proteins were also identified in a combination of two or three strains and absent in the remaining. Other proteins were detected only in T while absent in C, D, and F, including CTP synthetase, HP *Bp* 1123 and, a putative ketopantoate reductase among others. Conversely, proteins were detected exclusive to C, D, and F while not present in T, such as a putative periplasmic solute-binding protein. Lastly, proteins were identified exclusively to C, D, or F. These included HP *Bp* 3441, a trigger factor, and an exopolyphosphatase, respectively ([Table 2D](#T2){ref-type="table"}).

3.3. Direct putative immunoreactive protein identification using nLC ESI-MS/MS {#S16}
------------------------------------------------------------------------------

To identify putative antigenic proteins directly from the EMFs and to ascertain any differential immunoreactive proteomic profiles among the four strains, antigen-antibody (Ag-Ab) affinity capture technologies were employed. Trypsin-digested EMF proteins immunoprecipitated with coupled magnetic-bead strain-specific mouse antisera were analyzed via nLC-ESI MS/MS. Among each of the strains T, C, D, and F, 19, 31, 31, and 12 total "putative immunogenic proteins" (PIPs) were identified by database search analysis, respectively ([Table 3A](#T3){ref-type="table"}). Of the 48 total distinct PIPs detected between all 4 strains, 50% were membrane-associated with 60% of these proteins localized to the outer membrane and/or extracellular. The remaining 24 PIPs, accounting 23% and 27% were localized to the cytoplasm or of unknown location, respectively. For example, Prn, TonB, GroEL, EF-Tu, and a putative sulfatase were some of the proteins identified among all the strains ([Table 3B](#T3){ref-type="table"}). Collectively, the common PIPs (bold-black outlined box) detected in all T, C, D, and F strains were OmpQ, OmpP, putative lipoprotein, OmpA, BrkA, TcfA, and HP *Bp* 1440. Alternatively, a Vag8 autotransporter, preprotein translocase SecD (SecD), a putative peptidoglycan-associated protein, SCO1/SencC family and a thiol:disulfide interchange protein (DsbA) were identified in only C, D, and F (blue shaded box) and not detected in the T-EMF/Ab immunoprecipitated complex. Five, 11, and 9 strain-specific PIPs were detected in the T-, C- and D-EMF Ab-bead complexes. Included among those were HP *Bp* 0455, a putative inner membrane protein, and a putative bifunctional protein, respectively ([Table 3B](#T3){ref-type="table"}). No strain-specific PIPs were detected in the F-EMF/Ab IP complex. It is worth noting that varying degrees of cross-reactivity (CR) or nonspecific (NS) interactions were generated (denoted with an asterisk) using stable IP between the strains\' EMF to the normal mouse IgG-bound bead control. And these interactions can be reasonably explained from a biological perspective as depicted in [Fig. 3](#F3){ref-type="fig"}. TcfA, OmpP, and OmpA with evident cross reactivity were discovered in all 4 strains. Furthermore, the total PIPs correlating to mouse pertussis immunity comprised 11, 18, 18, and 7% of total T, C, D, and F surfaceome proteomic profiles, respectively ([Table 3A](#T3){ref-type="table"}). But taking any tentative cross-reactivity into consideration, subtracting the nonspecific interactions from the total number of PIPs resulted in a 23--39% reduction of more probable antigenic candidates.

Finally, we performed a MS-based immunoproteomic study using coupled magnetic bead-pooled human convalescent serum in combination with EMFs. This was to identify novel antigenic proteins that potentially correlate with human response to pertussis infection. The study, as summated in [Tables 4A and 4B](#T4){ref-type="table"}, revealed that human antibodies contained in the pooled serum immunoreacted with 4, 12, 8, and 10 proteins present in T-, C-, D-, and F-EMFs, respectively. Moreover, of the 15 total distinct PIPs detected by nLC-ESI MS/MS among all 4 strains, more than half were extracellular or localized to the outer membrane, including Vag8, BrkA, and TonB. Five proteins: HP *Bp* 0205, HP *Bp* 1485, HP *Bp* 3689, a probable inner membrane, and TonB revealed strain-specific detection in the human IP. Only two -- a probable inner membrane protein and HP *Bp* 3689 -- were unique to C and F, respectively. Once again, accounting for any non-specific interactions between normal human IgG antibodies and the EMFs, the pool of PIPs identified in this foundational assessment is diminished to 1, 3, 0, and 5 for T, C, D, and F, respectively. Lastly, in both the mouse and human immunoproteome examinations, 14 proteins were commonly identified, of which OmpQ and OmpA were the only proteins detected in all four immune complexes.

4. Discussion {#S17}
=============

In spite of widespread vaccination, disease caused by *Bp* is rapidly increasing in the United States. In this pilot study we compared the proteomes of one past *Bp* strain with three current circulating strains in which any subtle changes in their proteome profile could have pathogenic and immunological implications. Additionally, we employed a non gel-based technique to compare surface proteins and immunoproteins from the four *Bp* strains. Previous studies of bacterial surfaceomes for the identification of clinical diagnostic biomarkers (and more so, novel vaccine candidates) have all incorporated approaches that involve to a certain extent subproteome fractionation and gel-based separation followed by MS and protein identification ([@R40]). Our initial path of study in characterizing the surfaceomes of three recent *Bp* circulating isolates and one older isolate from 1954 began with a 1D-GE EMF protein assessment. This revealed no major protein banding differences or unique patterns. In an effort to maximize protein discovery, however, we implemented a gel-free surfaceome profiling approach. This proved advantageous and fruitful in identifying total proteins and was in partial concurrence with previous *Bp* surfaceome analysis.

[@R6] described a comparative surfaceome analysis of 3 *Bp* vaccine producing strains. The methodology included T and an Argentinean clinical isolate 106, in which 54 total proteins from enriched *Bp* surface extracts were identified using 2D-GE in parallel with matrix-assisted laser desorption ionization-time-of-flight (MALDI-TOF) MS analysis.

In our direct nLC-ESI MS/MS *Bp* surface assessment, 139 more proteins were identified than in the gel-based Bottero study ([@R6]). Bottero similarly identified 21 of the total 193 proteins, of which approximately 40% of this subset localized to the outer membrane. These included a competence lipoprotein, FHA, OmpQ, OmpP, OmpA, Prn, BrkA, and a putative quino protein. Among the cytoplasmic proteins, both studies discovered a capsular polysaccharide biosynthesis protein, putative [l]{.smallcaps}-lactate dehydrogenase, GroEL, and EF-Tu. And as summated in [Table 2D](#T2){ref-type="table"}, the remaining 172 proteins identified in our study were localized to the membrane or cytoplasm. They either "moonlight" (perform multiple cellular roles), serve in a cellular housekeeping capacity such as energy production, or engage in membrane-associated activities such as biogenesis, adhesion, or transport.

Our surfaceome profile resulted in a higher number of proteins identified. Given that our preparation is enriched and not exclusive for the surface membrane, more nonsorted cytoplasmic proteins may have been retained in the fraction compared with Bottero\'s enrichment method, thus resulting in more proteins in the starting material. Additionally, the profile generated is a direct analysis of a conformationally native in-solution protein pool versus a protein-embedded, gel excised spot or band. Consequently, this state would ideally allow proteolytic enzymes greater accessibility to the protein itself and result in a potentially higher yield of peptides generated by tryptic digestion. MALDI-TOF is a fruitful MS technology, in particular for its speed in analyzing a sample, but generally in terms of accuracy, peptide capacity, peptide resolution, and detection sensitivity, the nLC-ESI MS/MS used in our study is more advantageous and lends itself to higher numbers of proteins identified.

Other factors such as database annotation, peptide ionization potential, subproteome extraction, and protein abundance can also affect the success of protein identification. First, the *Bp* clinical isolates used in these studies have yet to be sequenced and thus are not present in the database. Therefore, some MS/MS data may not be matched to proteins in the existing database, resulting in lower protein discovery. Also, as in the case for both studies, due to amino acid composition (i.e., hydrophobic peptides) some peptides do not ionize well. Thus, their abundance may not be enough to trigger the mass spectrometer to conduct an MS/MS experiment. And some peptides may not fragment efficiently, leading to complete inability for the searching algorithm to match the data to the protein, irrespective of the MS instrumentation used. Again, due to chemical composition of the proteins and the extraction buffers utilized, some proteins may even be lost in the preparation ([@R6]; [@R2]). Note too that proteins commonly identified between both studies are cellularly abundant (i.e. EF-Tu) and large in molecular weight (i.e., FHA). Consequently, when these proteins are enzymatically digested they will likely generate more peptides that would have a greater propensity of detection. This could hinder the detection of smaller proteins, which obviously would have fewer tryptic peptides. Though our direct, gel-free, EMF nLC-ESI MS/MS analysis may require optimization of extraction steps to ensure a greater retention of outer membrane proteins and reduce "contamination" by abundant cytoplasmic proteins that may overshadow less abundant proteins, the approach can be used to examine other *Bp* circulating isolate surfaceomes for novel surface-expressed protein discovery.

The next phase of our study moved from elucidating what proteins comprised the enriched surfaceome to what proteins actually have the ability to induce an Ab-mediated response. We deviated from classical immunoblotting techniques, such as those used by [@R2], for a less-labor intensive, more rapid Ag--Ab affinity approach. The Ag--Ab method has an added benefit of identifying surface proteins with both continuous and noncontinuous epitopes while immunoblotting techniques generally can only probe continuous epitopes. Today, conjugated Ab-magnetic bead capture technologies are widely used for protein IP. Generally, protein G-coated magnetic Dynal™ beads capture from antisera IgG populations traditionally associated with direct Ab-mediated immune responses. This Ab-bead complex is immunoprecipitated or "pulled down" with proteins, if immunostimulatory would uniquely "match" and interact with its specific Ab. Once the protein-Ab-bead complex is pulled-down and washed to remove nonspecific binding, the beads are subjected to enzymatic digestion by trypsin and the peptides are analyzed by nLC-MS/MS. The respective proteins are identified by database searching.

[@R22] used this Ab-bead capture technology to identify anthrax spore surface proteins in response to human anthrax vaccine adsorbed-induced immunity. Here we similarly describe the use of Ag--Ab affinity for stable IP of *Bp* EMFs using strain-specific mouse-antisera, and couple this technique to MS to identify novel putative antigenic proteins. Of the 48 total proteins detected among our strains, 10 well-known immunogens were identified, including Vag8, GroEL, Prn, BipA, serotype 3 fimbrial subunit (Fim3), BrkA, OmpQ, OmpP, OmpA and TcfA ([@R42]; [@R33]; [@R13]; [@R12]; [@R29]; [@R46]). The latter five are commonly detected in all four strains. Other known *Bp* immunogens such as Ptx, FHA, Dnt, Fim2, or CyaA, the latter four identified in our total surfaceome profile, may have been immunoprecipitated and, due to peptide composition, simply not detected by MS. EF-Tu, EF-Ts, glyceraldehyde-3-phosphate dehydrogenase (Gdh), and a putative [l]{.smallcaps}-lactate dehydrogenase (Ldh) are immunogens commonly conserved in other pathogens ([@R46]; [@R8]; [@R26]) were also identified in our *Bp* affinity capture assessment. Additionally, [@R2] used strain-specific mouse antisera to perform a 2D-GE immunoproteomic study aimed at identifying novel immunogens in T and in the *Bp* Saadet strain, a 1948 Turkish isolate. The Altindis study discovered 25 total proteins, of which EF-Tu, Prn, BrkA, and ketol-acid reductoisomerase were comparably identified in all or some of the isolates in our examination. Even more, [@R39] described an extension of the 2009 Altindis study using 2D-GE in parallel with nLC-MS/MS to identify 11 more immunogens of *Bp* T and the Saadet strain, of which three -- Prn, GroEL and BrkA -- were, as stated, discovered in our study.

Identification of more similar proteins from the Altindis and Tefon studies is likely dependent on differential method design. Nevertheless, these proteins, along with the OmpP and OmpQ comparably identified in both our pilot immunoblot and IP study, in addition to the other known antigen identifications are confirmation that the capture technology is a fruitful alternate approach available for *Bp* immunogen discovery.

Of the remaining PIPs determined as common among T, C, D, and F, HP *Bp* 1440 and a putative lipoprotein are both possibly associated with transport and adhesion and could be considered as novel putative *Bp* antigens. Moreover, of the 5 PIPs only detected in the recent circulating C, D, and F isolates, only Vag8 was previously identified as immunogenic. The putative peptidoglycan associated-lipoprotein, SCO1/SenC family protein, DsbA, and SecD are proteins involved in outer membrane lipid attachment; membrane biogenesis and cytochrome c assembly, protein turnover, protein folding and energy production; and membrane protein secretion and export, respectively ([@R34]). Note too that their unique identification to the clinical strains could provide insight into the overall immunopathogenesis of past and recent pertussis cases.

Even more, immunogen screening via IP also identified PIPs unique to each strain. First, the T-EMF study detected five specific PIPs, one of which is BipA, a known immunogen. HP *Bp* 0455 and its *Bordetella bronchioseptica* (*Bb*) BB4955 homolog, both putatively associated with organic anion transport, also were identified ([@R34]), as were a putative inner membrane protein (*Bp* 3326) and a surface antigen, similar to the outer membrane protein assembly complex YaeT.

Second, the C-EMF study detected 11 specific PIPs, which included previously identified immunogens EF-Ts, GDH, LDH, and ketolacid reductoisomerase. Fructose 1-6-bisphosphate aldolase (Fba), N-acetyl-gamma-glutamyl-phosphate reductase (ArgC), and phosphor-2-dehydro-3-deoxyheptonate aldolase (AroG) are all metabolic enzymes involved in glycolysis, gluconeogenesis, or amino acid biosynthesis ([@R34]; [@R29]). Two proteins, similar to the bacterial, extracellular solute-binding protein family 7, exported solute-binding and periplasmic solute-binding (SmoM) were also found to be immunostimulatory ([@R34]; [@R29]). A rod-shape determining protein associated with the MreBCD complex was also identified.

Third, the D-EMF study detected nine specific PIPs, which included HP BP1057---a protein similar to *E. coli* Elab. A putative bifunctional protein, a metabolic protein similar to *P. aeruginosa* cytochrome c oxidase, and a F0F1 ATP synthase subunit B (an enzyme part of the membrane proton pump involved in ATP synthesis) were discovered. A probable *Bp* inner membrane protein and its homologous *Bb* translocase YidC, a membrane insertase, were identified as immunoreactive. A putative peptidase, associated with bacterial wall degradation and a signal peptidase I -- an enzyme similar to the essential membrane bound serine protease leader peptidase B -- were uniquely immunoprecipitated in the D antibody/EMF complex. A putative sulfatase containing phosphoglycerol transferase activity-like domains possibly associated with cell envelope biogenesis, was also discovered. Protective antibodies, for instance generated against this sulfatase, if not expressed in humans, could potentially impair bacterial cell growth and ultimately reduce infectivity and transmission of pertussis. Lastly, of the 14 PIPs identified in F, none were unique to this isolate.

Moreover, with differential and lower immunoreactivity among the strains, as in the case with strain F, one may wonder why variation exists and the usefulness of strain-specific PIPs as potential candidates for clinical diagnostics and improved vaccine development. First, an important reminder is that *Bp* T is a lab-adapted strain in which virulence observed over the years may have weakened, reducing its immunopotency and contributing to fewer PIPs identified.

Second, C, D, and F strains all were isolated in different U.S. geographical regions between 1998 and 2007 and presumably from different individuals, thus, the identification of unique, strain-specific PIPs is not unlikely. Also, although *Bp* T, C, D, and F OMP extraction and enrichments were performed under the same conditions and time, some proteins exhibiting antigenic properties might have been lost during the preparation process. Nevertheless, regardless of strain differences, all the aforementioned PIP biological roles could prove insightful into the overall immunopathogenesis of *Bp* and provide a greater epidemiological understanding of pertussis incidence and how better to diagnose, treat, and -- most importantly -- prevent the disease.

As alluded, though specific Ag--Ab interactions were formed and measures taken in the method to reduce nonspecific binding, cross-reactivity of strain-specific Ags from the EMFs to normal mouse IgG-bound bead controls was observed. Proteins commonly immunoprecipitated in all strains, such as OmpQ and OmpA, exhibit cross-reactive or nonspecific tendencies and are reasonably explained from a biological perspective ([Fig. 3](#F3){ref-type="fig"}). First, the EMF protein interactive with the Ab-bead in its natural state exists as a complex. Second, because not all of the available sites on the protein G-beads will be occupied by IgG-specific antibodies, *Bp* proteins present in the EMF with biochemical properties that allow for interaction directly to the protein G could exist. Third, *Bp* proteins could nonspecifically bind to glycoprotein-antibody moieties. Also, cross-reactivity may simply persist due to protein abundance in which residual amounts of detectable protein remain even after several washes upon IP and before protein digestion. Under all of these scenarios, upon tryptic digestion not only the bound specific protein is digested, but also those making up complex formations are digested as well, all of which could be simply considered as nonspecific. With all that said, regardless of the origin of cross-reactivity, identified immunogens are merely putative. To be considered true candidates as biomarkers for clinical diagnostics and improved vaccine development, they have to be validated extensively on a proteomic level and, most importantly, in vivo.

Information gained from immunoproteomic studies that use *Bp*-generated mouse antisera as the basis for novel immunogen discovery are quite valuable to identify possible immunoreactive proteins. But individual, *Bp*-stimulated human antibody or pooled serum from actively infected or even convalescent pertussis patients is more ideal and provides a more relevant immunological perspective of human pertussis infection. In our study, 15 total PIPs among T, C, D, and F were recognized by pooled human antibodies from patients recovering from pertussis infection---a more than 3-fold reduction in total PIPs identified using the mouse model. Moreover, strain-specific antisera generated from whole inactivated *Bp* T, C, D, and F from immunized animals versus a pooled serum from convalescent pertussis-infected human patients are a clear factor that may play a role in differential immunoreactivity. Although not comparable with methodologies performed in our study, [@R46] recently described a 2D-GE proteomic assessment of total *Bp* membrane enriched and extracellular protein preparations. The purpose was to investigate the complete set of *Bp* antigenic proteins using antisera generated in response to Chinese whole-cell, vaccine-induced immunity.

In the Zhu study, twice as many total immunogens were identified for human sera compared with our human sera pool. The disparity was possibly due to *Bp* strain differences and lower post-pertussis infection specific circulating Ab titer levels of the pooled human antisera (caused by prior serum dilution) used in our study. Interestingly, irrespective of the subproteome extraction, protein enrichment, and immunodetection methods used, OmpQ was the only protein pulled down using both mouse and human antisera from all four *Bp* EMFs in our study, as well as in Zhu\'s immunoproteomic examinations.

In conclusion, we used Ag--Ab affinity capture technologies in conjunction with MS to identify immunoreactive proteins in three recent circulating *Bp* strains. The overall goals were to identify biomarkers that could be evaluated for use in pertussis strain differentiation and in clinical diagnostics, and to detect novel targets for design of prevention and therapeutic strategies.

As a first step in this qualitative proteomics study, we examined the applicability of a gel-free direct enzymatic-treated *Bp* EMF surfaceome analysis. Common and strain-specific surface expressed protein profiles compared to the current vaccine-producing T strain were generated, suggesting that there may be subtle differences of surface protein expression among *Bp* strains. Further characterization of these differentially expressed proteins at the molecular level is warranted; which may reveal minor changes that could have implications on virulence and pathogenesis.

Second, antibodies generated from pertussis interperitoneal mouse inoculation were used to assess protein immunogenicity and revealed the identification of known and unknown *Bp* antigens using a stable IP approach. A comprehensive proteomic examination and an in vivo immunopotency assessment are further needed to validate these PIPs as true biomarker and vaccine candidates. Also, reassessing the immunoproteome of our unique *Bp* strains by stable IP using several human sera from active pertussis infected human patients will provide a more consistent depiction of the pertussis immunoproteome. Additionally, efforts to enhance novel immunogen discovery may require immunodepletion of known and highly abundant antigenic-specific antibody populations, such as OmpQ and BrkA. Highly abundant antigenic proteins would in essence generate a larger specific IgG antibody pool. This larger antibody subset would have a greater chance of binding to protein G-beads, which invariably could overshadow lower expressed immunostimulatory proteins.

Nonetheless, the gel-free approach described here for immunoproteome identification remains a fruitful alternative for antigen discovery. And because this is a pilot study using a small number of temporally limited and genetically diverse strains, future studies will entail using the described methods to examine a larger set of epidemiologically significant strains with these putative, novel candidates laying the foundation for clinical diagnostic design and improved vaccine development, leading to the ultimate prevention of this deadly infection.
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![Flow diagram of core methodologies used in the proteomic study. Red Asterisk (\*) indicates the mouse sera was used for the immunoblot analysis and immunoprecipitation. Black asterisk (\*) indicates human convalescent sera was used for the immunoprecipitation.](nihms915987f1){#F1}

![SDS-PAGE of *Bp* T, C, D, and F enriched membrane fractions (EMF). 10 µg of total carbonate-extracted EMF proteins from each strain was suspended in Laemmli sample buffer, electrophoresed on 12.5% SDS-PAGE gels, and stained using the hot coomassie blue staining protocol. Abbreviation: T --- Tohama I, C --- C056, D --- D946 and F --- F656; SDS-PAGE --- sodium dodecyl sulfate-polyacrylamide gel electrophoresis.](nihms915987f2){#F2}

![Illustration of potential specific and non-specific interactions during an immunoprecipitation (IP) from a biological and technical perspective.](nihms915987f3){#F3}

###### 

Genomic profiles of *Bordetella pertussis* (*Bp*) strains assessed in the study.

  Strain   Isolation location (Year)    PFGE           Pertactin   Pertussis toxin
  -------- ---------------------------- -------------- ----------- -----------------
  T        Japan (1954)                 Type II        *prnA1*     *ptxS1B*
  C        Minnesota, USA (1998)        CDC type I0    *prnA2*     *ptxS1A*
  D        Georgia, USA (2002)          CDC type 21    *prnA1*     *ptxS1A*
  F        Virgin Islands, USA (2007)   CDC type 206   *prnA2*     *ptxS1A*

Abbreviations: T --- Tohama I, C --- C056, D --- D946 and F --- F656; USA --- United States of America; CDC --- Centers for Disease Control and Prevention; PFGE --- pulse field gel electrophoresis; Prn --- pertactin; Ptx --- pertussis toxin.

  A Summary of the total number of *Bp* enriched membrane fraction (EMF) proteins commonly and uniquely identified among the *Bp* strains assessed in the study.   
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------
  Strains                                                                                                                                                          Total number of proteins
                                                                                                                                                                   
  T                                                                                                                                                                182
  C                                                                                                                                                                175
  D                                                                                                                                                                175
  F                                                                                                                                                                176
  Strain combinations                                                                                                                                              Total number of common proteins
                                                                                                                                                                   
  T, C, D, and F                                                                                                                                                   163
  T and C only                                                                                                                                                     1
  T and D only                                                                                                                                                     3
  T and F only                                                                                                                                                     0
  C and D only                                                                                                                                                     0
  C and F only                                                                                                                                                     0
  D and F only                                                                                                                                                     0
  T, C and D only                                                                                                                                                  1
  T, C and F only                                                                                                                                                  5
  T, D and F only                                                                                                                                                  2
  C, D and F only                                                                                                                                                  3
  Strains                                                                                                                                                          Total number of unique proteins
                                                                                                                                                                   
  T only                                                                                                                                                           7
  C only                                                                                                                                                           2
  D only                                                                                                                                                           3
  F only                                                                                                                                                           3

  B Subcellular localization of identified *Bp* EMF proteins (\*\* --- Table 2A).
  ---------------------------------------------------------------------------------

  C Protein function of identified *Bp* EMF proteins (\*\* --- Table 2A).
  -------------------------------------------------------------------------

  D Summary of *Bp* EMF proteins identified among *Bp* strains assessed in the study (\*\* --- Table 2A).                                                                                      
  --------------------------------------------------------------------------------------------------------- ----------- --------- ------- ----- ------ --------- --------- --------- --------- --------------------------
  30S ribosomal protein S2                                                                                  NP_880161   BP1419    rpsB    28    C      28 (4)    23 (3)    21 (3)    23 (3)    Translation
  30S ribosomal protein S3                                                                                  NP_882129   BP3619    rpsC    29    C      27 (4)    27 (4)    27 (5)    27 (4)    Translation
  50S ribosomal protein L16                                                                                 NP_882130   BP3620    rplP    15    C      26 (3)    36 (4)    19 (2)    29 (3)    Translation
  50S ribosomal protein L18                                                                                 NP_882141   BP3632    rplR    13    C      20 (2)    20 (2)    30 (3)    20 (2)    Translation
  50S ribosomal protein L2                                                                                  NP_882126   BP3616    rplB    30    C      14 (3)    11 (2)    11 (2)    17 (3)    Translation
  50S ribosomal protein L5                                                                                  NP_882137   BP3628    rplE    20    C      17 (3)    12 (2)    12 (2)    18 (3)    Translation
  50S ribosomal protein L6                                                                                  NP_882140   BP3631    rplF    19    C      27 (3)    27 (3)    27 (3)    19 (2)    Translation
  2-Isopropylmalate synthase                                                                                NP_879030   BP0131    leuA    62    U      6 (2)     14 (5)    8 (3)     11 (4)    Metabolism
  5-Meta[\^](#TFN7){ref-type="table-fn"}                                                                    NP_881170   BP2543    metA    84    U      1 (1)     4 (2)     4 (2)     4 (2)     Metabolism
  ABC transporter                                                                                           NP_879529   BP0697    U       29    CM     22 (3)    22 (3)    27 (4)    28 (4)    Membrane transport
  Acteyl-CoA carboxylase carboxyltransferase subunit alpha                                                  NP_880596   BP1910    accA    35    C      17 (4)    29 (6)    24 (5)    17 (4)    Metabolism
  Aconitate hydratase                                                                                       NP_880684   BP2014    acnA    99    C      5 (3)     5 (3)     3 (2)     4 (2)     Metabolism
  Acriflavine resistance protein B                                                                          NP_879779   BP0985    acrB    116   CM     6 (4)     3 (2)     5 (3)     3 (2)     Drug resistance
  Adenylosuccinate lyase                                                                                    NP_881474   BP2890    purB    50    C      7 (3)     5 (2)     9 (3)     9 (3)     Metabolism
  Alanyl-tRNA synthetase                                                                                    NP_880538   BP1836    alaS    96    C      15 (10)   9 (6)     8 (6)     8 (5)     Translation
  ATP-dependent protease La                                                                                 NP_880488   BP1777    Ion     90    C      5 (4)     5 (3)     6 (4)     5 (3)     Metabolism
  Autotransporter                                                                                           NP_880953   BP2315    vag8    101   OM/E   24 (15)   37 (22)   28 (18)   38 (22)   Transport
  Autotransporter subtilisin-like protease                                                                  CAC44081    U         sphB1   114   OM/E   14 (9)    16 (9)    23 (15)   17 (10)   Transport
  Bifunctional aconitate hydratase 2/2-methylisocitrate dehydratase                                         NP_880691   BP2021    acnB    95    C      8 (5)     6 (3)     9 (6)     6 (3)     Metabolism
  Bifunctional hemolysin-adenylate cyclase precursor                                                        NP_879578   BP0760    cyaA    188   E      8 (8)     18 (20)   10 (12)   14 (15)   Metabolism
  Capsular polysaccharide biosynthesis protein                                                              NP_880357   BP1629    wbpO    47    C      13 (3)    13 (3)    10 (2)    10 (2)    Metabolism
  Cell division protein                                                                                     NP_879861   BP1077    ftsH    69    CM     20 (9)    15 (6)    12 (6)    15 (7)    Cell division
  Cell division protein FtsA                                                                                NP_881594   BP3019    ftsA    45    C      18 (5)    18 (5)    17 (5)    14 (4)    Cell division
  Chain A, structure of the membrane protein Fhac                                                           2QDZ_A      U         U       61    OM     22 (6)    26 (8)    25 (8)    27 (9)    Transport
  Chaperonin GroEL                                                                                          NP_882014   BP3495    groEL   60    C      16 (5)    13 (5)    20 (8)    12 (5)    RNA degradation
  Competence lipoprotein                                                                                    NP_879922   BP1146    comL    29    OM     21 (4)    12 (2)    26 (5)    16 (3)    Transport
  Cytochrome C1 precursor                                                                                   NP_879155   BP0275    petC    31    U      34 (6)    24 (4)    13 (3)    29 (4)    Metabolism
  [d]{.smallcaps}-fructose-6-phosphate amidotransferase[\^](#TFN7){ref-type="table-fn"}                     NP_879503   BP0666    glmS    67    C      7 (3)     4 (1)     10 (4)    8 (3)     Metabolism
  Dihydrolipoamide acetyltransferase[\^](#TFN7){ref-type="table-fn"}                                        NP_879904   BP1125    odhB    44    CM     3 (1)     24 (4)    19 (3)    11 (2)    Metabolism
  Dihydroorotate dehydrogenase 2                                                                            NP_881968   BP3442    pyrD    38    CM     21 (4)    18 (3)    18 (3)    13 (2)    Metabolism
  Dihydroxy-acid dehydratase                                                                                NP_879169   BP0289    ilvD    68    C      7 (3)     5 (2)     5 (2)     5 (2)     Metabolism
  DNA gyrase subunit B                                                                                      NP_879342   BP0489    gyrB    90    C      4 (2)     7 (4)     3 (2)     5 (3)     DNA synthesis
  DNA topoisomerase III[\^](#TFN7){ref-type="table-fn"}                                                     NP_879317   BP0460    topB    96    C      9 (5)     9 (5)     8 (4)     2 (1)     DNA synthesis
  DNA-directed RNA polymerase subunit beta                                                                  NP_878932   BP0015    rpoB    151   C      3 (2)     7 (7)     5 (5)     4 (4)     Metabolism
  DNA-directed RNA polymerase subunit beta                                                                  NP_878933   BP0016    rpoC    155   C      3 (3)     4 (4)     3 (4)     2 (2)     Metabolism
  Elongation factor G                                                                                       NP_882120   BP3610    fusA    77    C      26 (11)   24 (10)   13 (6)    20 (9)    Translation
  Elongation factor Tu                                                                                      NP_878925   BP0007    tuf     44    C      38 (9)    31 (7)    21 (5)    33 (8)    Translation
  Enoyl- (acyl carrier protein) reductase[\^](#TFN7){ref-type="table-fn"}                                   NP_881766   BP3215    fabL    29    CM     5 (1)     9 (2)     9 (2)     4 (1)     Lipid metabolism
  F0F1 ATP synthase subunit alpha[\^](#TFN7){ref-type="table-fn"}                                           NP_881828   BP3286    atpA    56    C      8 (3)     5 (2)     11 (4)    2 (1)     Energy metabolism
  F0F1 ATP synthase subunit B                                                                               NP_881826   BP3284    atpF    17    CM     30 (4)    30 (4)    43 (6)    37 (5)    Energy metabolism
  F0F1 ATP synthase subunit beta                                                                            NP_881830   BP3288    atpD    51    CM     17 (5)    23 (6)    7 (2)     15 (3)    Energy metabolism
  Filamentous hemagglutinin/adhesion                                                                        NP_880571   BP1879    fhaB    394   OM     18 (43)   16 (37)   16 (38)   15 (34)   Adherence
  Glutamate synthase \[NADPH\] large chain precursor                                                        NP_882256   BP3753    qltb    174   C      7 (7)     3 (4)     2 (2)     6 (6)     Amino acid metabolism
  Guanosine-3\',5\'-bis (diphosphate) 3\'-pyrophosphohydrolase                                              NP_880309   BP1576    spoT    83    U      5 (3)     7 (4)     5 (3)     10 (6)    Nucleotide metabolism
  Histone protein                                                                                           NP_881561   BP2985    bpH1    19    C      18 (2)    18 (2)    18 (2)    18 (2)    DNA synthesis
  HlyD family secretion protein[\^](#TFN7){ref-type="table-fn"}                                             NP_882313   BP3815    hlyD    46    CM     10 (2)    5 (1)     13 (3)    10 (2)    Signal transduction
  Homoserine dehydrogenase[\^](#TFN7){ref-type="table-fn"}                                                  NP_881384   BP2784    U       48    C      15 (4)    18 (5)    5 (1)     18 (5)    Amino acid metabolism
  Hypothetical protein BP0162                                                                               NP_879055   BP0162    HP      37    U      14 (3)    9 (2)     23 (4)    23 (4)    HP
  Hypothetical protein BP0205                                                                               NP_879093   BP0205    HP      21    U      44 (7)    47 (8)    39 (6)    44 (7)    HP/transport
  Hypothetical protein BP0325[\^](#TFN7){ref-type="table-fn"}                                               NP_879200   BP0325    HP      43    CM     3 (1)     8 (3)     3 (1)     5 (2)     HP/membrane transport
  Hypothetical protein BP0387                                                                               NP_879258   BP0387    HP      27    P      27 (4)    21 (3)    32 (5)    30 (4)    HP
  Hypothetical protein BP0606                                                                               NP_879449   BP0606    HP      15    U      23 (2)    31 (3)    31 (3)    23 (2)    HP
  Hypothetical protein BP1057                                                                               NP_879842   BP1057    HP      12    U      51 (3)    23 (2)    23 (2)    39 (2)    HP
  Hypothetical protein BP1426                                                                               NP_880168   BP1426    HP      49    CM     20 (5)    11 (3)    7 (2)     11 (3)    HP
  Hypothetical protein BP1438                                                                               NP_880180   BP1438    HP      16    U      16 (2)    16 (2)    15 (2)    16 (2)    HP
  Hypothetical protein BP1440                                                                               NP_880182   BP1440    HP      34    U      42 (8)    36 (7)    44 (8)    42 (9)    HP/protein stability
  Hypothetical protein BP1485                                                                               NP_880222   BP1485    HP      58    C      42 (12)   25 (8)    31 (9)    31 (D)    HP/protein transport
  Hypothetical protein BP1903                                                                               NP_880589   BP1903    HP      58    CM     5 (2)     7 (2)     7 (3)     7 (2)     HP
  Hypothetical protein BP2141[\^](#TFN7){ref-type="table-fn"}                                               NP_880795   BP2141    HP      17    U      9 (1)     24 (2)    24 (2)    31 (3)    HP
  Hypothetical protein BP2191                                                                               NP_880839   BP2191    hflK    48    U      35 (8)    22 (5)    32 (8)    35 (9)    HP
  Hypothetical protein BP2197                                                                               NP_880845   BP2197    HP      23    U      25 (3)    47 (6)    32 (4)    35 (4)    HP
  Hypothetical protein BP2323                                                                               NP_880961   BP2323    HP      28    U      24 (3)    18 (2)    18 (2)    18 (2)    HP
  Hypothetical protein BP2534                                                                               NP_881161   BP2534    HP      58    U      25 (8)    18 (6)    18 (6)    17 (7)    HP/metabolism
  Hypothetical protein BP2535                                                                               NP_881162   BP2535    HP      43    CM     34 (8)    34 (8)    14 (4)    29 (7)    HP/metabolism
  Hypothetical protein BP2661[\^](#TFN7){ref-type="table-fn"}                                               NP_881275   BP2661    HP      32    U      10 (2)    5 (1)     10 (2)    10 (2)    HP/transport
  Hypothetical protein BP2717                                                                               NP_881325   BP2717    HP      40    M/U    29 (5)    14 (3)    5 (2)     28 (5)    HP
  Hypothetical protein BP2936                                                                               NP_881518   BP2936    HP      37    U      23 (6)    17 (4)    36 (9)    33 (8)    HP
  Hypothetical protein BP3467                                                                               NP_881990   BP3467    HP      92    U      15 (7)    15 (7)    10 (5)    14 (7)    HP/membrane biogenesis
  Hypothetical protein BP3521                                                                               NP_882036   BP3651    HP      61    C      7 (3)     6 (2)     5 (2)     7 (3)     HP/membrane biogenesis
  Hypothetical protein BP3559                                                                               NP_882072   BP3559    HP      39    M/U    30 (6)    32 (6)    29 (6)    20 (4)    HP/cell division
  Hypothetical protein BP3651                                                                               NP_882159   BP3651    HP      77    U      7 (3)     7 (3)     9 (4)     8 (3)     HP/membrane biogenesis
  Hypothetical protein BP3689 (LysM domain/BON SFP)                                                         NP_882194   BP3689    HP      20    U      24 (3)    22 (3)    22 (3)    22 (3)    HP/cell wall degradation
  Hypothetical protein BP3758[\^](#TFN7){ref-type="table-fn"}                                               NP_882261   BP3758    HP      29    CM     3 (1)     5 (1)     7 (2)     7 (2)     HP/membrane transport
  Hypothetical protein BP3819                                                                               NP_882317   BP3819    HP      27    U      12 (2)    23 (3)    19 (2)    19 (2)    HP
  [l]{.smallcaps}-lactate dehydrogenase                                                                     NP_879338   BP0484    ildD    43    C      16 (4)    19 (3)    8 (2)     28 (6)    Carbohydrate metabolism
  Large-conductance mechanosensitive channel                                                                NP_879158   BP0278    mscl    17    U      25 (3)    25 (3)    13 (2)    25 (3)    Transport
  Lipoprotein[\^](#TFN7){ref-type="table-fn"}                                                               NP_881354   BP2750    HP      24    U      13 (2)    13 (2)    11 (2)    7 (1)     U
  Lipoprotein                                                                                               NP_879963   BP1189    U       16    U      24 (2)    39 (3)    39 (3)    25 (2)    U
  Mce related protein                                                                                       NP_882262   BP3759    U       18    U      59 (4)    35 (2)    73 (5)    45 (3)    Transport
  Outer membrane lipoprotein                                                                                NP_881135   BP2508    omlA    20    OM     34 (3)    29 (3)    40 (4)    47 (5)    Transport
  Outer membrane porin protein OmpQ                                                                         NP_881933   BP3405    ompQ    40    OM     30 (8)    27 (7)    23 (6)    29 (8)    Transport
  Outer membrane porin protein precursor                                                                    NP_879650   BP0840    U       42    OM     52 (12)   43 (10)   47 (10)   43 (10)   Transport
  Outer membrane protein A precursor                                                                        NP_879744   BP0943    ompA    21    OM     44 (7)    39 (5)    39 (6)    44 (6)    Transport
  Outer membrane usher protein precursor                                                                    NP_880573   BP1882    fimC    96    OM     10 (6)    11 (6)    13 (9)    11 (7)    Membrane biogenesis
  Penicillin-binding protein 1A                                                                             NP_882163   BP3655    U       90    E      9 (3)     11 (4)    10 (4)    11 (5)    Peptidoglycan metabolism
  Putative peptidoglycan-associated lipoprotein                                                             NP_881875   BP3342    U       18    OM     59 (7)    59 (6)    67 (8)    53 (7)    Transport
  Peptidyl-prolyl cis-trans isomerase D                                                                     NP_880447   BP1732    ppiD    7     U      45 (16)   38 (13)   38 (14)   36 (12)   Protein folding
  Pertactin                                                                                                 BAF35031    U         prn     101   OM     21 (13)   17 (11)   14 (8)    15 (9)    Transport
  Phosphoenolpyruvate synthase                                                                              NP_880178   BP1436    ppsA    87    C      9 (6)     3 (2)     5 (3)     3 (2)     Carbohydrate metabolism
  Phosphoglucomutase/phosphomannomutase                                                                     NP_879859   BP1075    qlmM    50    C      9 (3)     6 (2)     6 (2)     6 (2)     Carbohydrate metabolism
  Preprotein translocase subunit SecA                                                                       NP_881589   BP3014    secA    100   CM     10 (7)    6 (4)     2 (2)     2 (2)     Membrane transport
  Preprotein translocase subunit SecD                                                                       NP_879831   BP1046    secD    69    CM     28 (11)   23 (10)   29 (11)   26 (10)   Membrane transport
  Preprotein translocase subunit SecF                                                                       NP_879830   BP1045    secF    34    CM     19 (3)    19 (3)    19 (3)    19 (3)    Membrane transport
  Preprotein translocase subunit SecG                                                                       NP_879617   BP0802    secG    16    U      41 (2)    41 (2)    41 (2)    41 (2)    Membrane transport
  Putative ABC transporter                                                                                  NP_880959   BP2321    Pu      69    CM     16 (5)    10 (3)    15 (4)    15 (4)    Transport
  Putative ABC transporter ATP-binding subunit[\^](#TFN7){ref-type="table-fn"}                              NP_881029   BP2397    Pu      70    CM     7 (2)     8 (2)     2 (1)     5 (1)     Membrane transport
  Putative ABC transporter ATP-binding subunit[\^](#TFN7){ref-type="table-fn"}                              NP_880660   BP1986    Pu      70    CM     3 (1)     11 (4)    7 (2)     7 (2)     Membrane transport
  Putative ABC transporter ATP-binding subunit                                                              NP_882260   BP3757    Pu      31    CM     19 (3)    29 (4)    29 (4)    23 (4)    Membrane transport
  Putative ABC transporter ATP-binding subunit                                                              NP_880723   BP2057    Pu      46    CM     34 (7)    28 (6)    6 (2)     24 (5)    Membrane transport
  Putative amino acid ABC transporter ATP-binding protein                                                   NP_882326   BP3828    Pu      27    CM     20 (3)    15 (2)    20 (3)    15 (2)    Membrane transport
  Putative amino acid ABC transporter permease protein                                                      NP_882328   BP3830    Pu      44    CM     13 (3)    8 (2)     8 (2)     8 (2)     Membrane transport
  Putative bifunctional protein                                                                             NP_882247   BP3744    Pu      43    CM     22 (6)    17 (4)    12 (3)    17 (4)    Energy metabolism
  Putative binding-protein-dependent transport permease                                                     NP_881026   BP2394    Pu      33    CM     5 (1)     3 (1)     7 (2)     5 (1)     Membrane transport
  Putative binding-protein-dependent transport protein                                                      NP_881859   BP3322    Pu      42    P      41 (7)    27 (6)    33 (6)    26 (4)    Membrane transport
  Putative cell division protein[\^](#TFN7){ref-type="table-fn"}                                            NP_881100   BP2473    Pu      87    CM     5 (2)     2 (1)     4 (1)     4 (3)     Cell division
  Putative chromosome partition protein                                                                     NP_882071   BP3558    Pu      130   C      7 (6)     11 (7)    9 (6)     8 (6)     Cell division
  Putative dioxygenase                                                                                      NP_880971   BP2333    Pu      34    CM     16 (3)    19 (4)    11 (2)    19 (4)    Amino acid metabolism
  Putative efflux system inner membrane protein                                                             NP_880738   BP2075    Pu      49    CM     14 (4)    18 (5)    14 (4)    14 (4)    Membrane transport
  Putative efflux system transmembrane protein                                                              NP_880739   BP2076    Pu      118   CM     12 (9)    5 (4)     8 (7)     10 (7)    Membrane transport
  Putative exported solute binding protein                                                                  NP_881542   BP2963    Pu      40    U      17 (4)    10 (2)    10 (2)    13 (3)    Membrane transport
  Putative extracellular solute-binding protein                                                             NP_880657   BP1983    Pu      82    P      6 (3)     6 (3)     6 (3)     6 (3)     Membrane transport
  Putative glycosyl transferase                                                                             NP_881785   BP3238    Pu      34    U      20 (4)    10 (2)    12 (2)    22 (4)    Metabolism
  Putative inner membrane protein                                                                           NP_881862   BP3326    Pu      26    U      27 (4)    27 (4)    28 (4)    49 (6)    HP
  Putative inner membrane protein translocase component YidC                                                NP_886531   BBP4405   Pu      62    CM     9 (3)     15 (4)    12 (4)    7 (3)     Membrane transport
  Putative inner membrane-anchored protein                                                                  NP_880838   BP2190    Pu      33    U      16 (4)    20 (5)    20 (4)    15 (3)    HP
  Putative integral membrane protein                                                                        NP_881049   BP2420    Pu      41    CM     9 (2)     12 (2)    16 (4)    7 (2)     Membrane transport
  Putative [l]{.smallcaps}-lactate dehydrogenase                                                            NP_879251   BP0379    Pu      39    C      7 (2)     18 (3)    18 (3)    21 (4)    Carbohydrate metabolism
  Putative lipoprotein                                                                                      NP_880735   BP2072    Pu      22    U      24 (3)    27 (3)    24 (3)    18 (2)    Putative transport
  Putative lipoprotein                                                                                      NP_881568   BP2992    Pu      18    OM     59 (6)    49 (5)    53 (5)    53 (5)    Putative transport
  Putative lipoprotein                                                                                      NP_882263   BP3760    Pu      29    OM     13 (2)    25 (4)    16 (4)    11 (3)    Putative transport
  Putative lipoprotein                                                                                      NP_880063   BP1296    Pu      30    U      16 (3)    12 (2)    12 (2)    12 (2)    U
  Putative lipoprotein                                                                                      NP_880303   BP1296    Pu      41    U      26 (5)    30 (6)    22 (5)    30 (7)    Putative membrane
  Putative lipoprotein                                                                                      NP_880710   BP2043    Pu      24    U      26 (4)    15 (2)    23 (4)    11 (2)    U
  Putative membrane transport ATPase                                                                        NP_881330   BP2722    Pu      86    CM     4 (2)     4 (2)     3 (2)     5 (2)     Putative transport
  Putative membrane transport protein                                                                       NP_881309   BP2716    Pu      49    U      7 (2)     7 (2)     11 (3)    7 (2)     Putative transport
  Putative NADH dehydrogenase                                                                               NP_882010   BP3491    ndh     48    CM     10 (3)    6 (2)     6 (2)     6 (2)     Energy metabolism
  Putative outer membrane (permeability) protein                                                            NP_881865   BP3329    Pu      87    OM     16 (7)    9 (4)     12 (6)    10 (5)    Putative transport
  Putative outer membrane ligand binding protein                                                            NP_879893   BP1112    bipA    144   OM     39 (28)   15 (12)   23 (17)   13 (12)   Adherence
  Putative peptidase                                                                                        NP_880436   BP1721    Pu      32    OM     22 (3)    20 (3)    20 (3)    27 (4)    Protein degradation
  Putative quinoprotein                                                                                     NP_880844   BP2196    Pu      42    OM     31 (6)    29 (5)    38 (7)    20 (4)    Protein assembly
  Putative secreted protein[\^](#TFN7){ref-type="table-fn"}                                                 NP_879832   BP1047    Pu      13    U      32 (2)    32 (2)    32 (2)    21 (1)    Membrane transport
  Putative secretion system protein                                                                         NP_882292   BP3793    ptle    26    U      14 (3)    21 (4)    17 (3)    16 (3)    Putative transport
  Putative secretion system protein                                                                         NP_882293   BP3794    ptlf    30    U      11 (2)    19 (3)    19 (3)    11 (2)    Putative transport
  Putative secretion system protein                                                                         NP_882289   BP3794    ptlc    91    CM     6 (3)     9 (5)     9 (5)     11 (6)    Putative transport
  Putative sugar transport protein[\^](#TFN7){ref-type="table-fn"}                                          NP_881176   BP2549    Pu      61    CM     5 (2)     2 (1)     5 (2)     5 (2)     Putative transport
  Putative sulfatase                                                                                        NP_881701   BP3136    Pu      72    CM     21 (8)    10 (5)    17 (8)    17 (8)    Membrane biogenesis
  Putative TolQ-like translocation protein                                                                  NP_881879   BP3346    Pu      25    CM     22 (3)    22 (3)    23 (4)    19 (3)    Membrane transport
  Putative type III secretion protein                                                                       NP_880879   BP2235    Pu      66    CM     8 (3)     10 (3)    12 (5)    12 (4)    Membrane transport
  Pyrroline-5-carboxylate reductase                                                                         NP_880048   BP1280    proC    30    C      15 (3)    15 (3)    10 (2)    11 (2)    amino acid metabolism
  RecA                                                                                                      AAK85426    U         recA    31    C      36 (6)    31 (5)    28 (4)    22 (4)    DNA processing
  Ribonuclease E                                                                                            NP_879331   BP0475    rne     115   C      12 (8)    8 (5)     6 (4)     8 (5)     RNA degradation
  Ribonucleotide-diphosphate reductase subunit alpha                                                        NP_881559   BP2983    nrdA    107   C      10 (7)    5 (3)     3 (2)     8 (5)     Nucleotide metabolism
  RNA polymerase sigma 80 subunit                                                                           AAC45085    BP1191    rpoD    81    C      9 (4)     5 (2)     6 (3)     6 (2)     RNA processing
  Rod shape-determining protein                                                                             NP_879246   BP0374    mreB    38    C      16 (3)    19 (4)    8 (2)     12 (3)    Cell morphology
  SCO1/SenC family protein[\^](#TFN7){ref-type="table-fn"}                                                  NP_882237   BP3734    U       22    U      17 (3)    6 (1)     10 (2)    6 (1)     Transport
  Serum resistance protein                                                                                  NP_882013   BP3494    brkA    111   OM     23 (14)   27 (14)   29 (17)   38 (21)   Transport
  Signal peptidase I                                                                                        NP_881060   BP2432    lep     32    CM     11 (2)    19 (4)    14 (3)    12 (2)    Transport
  Succinate dehydrogenase flavoprotein subunit[\^](#TFN7){ref-type="table-fn"}                              NP_880997   BP2361    sdhA    65    CM     7 (3)     7 (3)     3 (1)     11 (5)    Carbohydrate metabolism
  Succinate dehydrogenase iron--sulfur protein[\^](#TFN7){ref-type="table-fn"}                              YP_785707   BAV1185   sdhB    26    CM     4 (1)     14 (4)    9 (3)     14 (3)    Carbohydrate metabolism
  Succinyl-CoA synthetase subunit beta                                                                      NP_881168   BP2541    sucC    42    U      14 (3)    9 (2)     9 (2)     17 (4)    Carbohydrate metabolism
  Surface antigen                                                                                           NP_880169   BP1427    U       86    OM     29 (15)   29 (15)   25 (13)   35 (18)   Protein assembly
  Tex                                                                                                       CAA64672    BP1144    tex     87    C      5 (3)     4 (2)     3 (2)     4 (2)     RNA processing
  Thiol:disulfide interchange protein                                                                       NP_882154   BP3646    DsbA    71    CM     15 (7)    14 (6)    14 (6)    10 (4)    Membrane biogenesis
  Threonine synthase                                                                                        NP_881383   BP2783    thrC    51    C      16 (5)    31 (9)    10 (3)    17 (5)    Amino acid metabolism
  TonB-dependent receptor for iron transport                                                                NP_879666   BP0856    bfrD    82    OM     34 (20)   35 (21)   29 (18)   28 (15)   Membrane transport
  Tracheal colonization factor precursor                                                                    NP_879974   BP1201    tcfA    71    OM     12 (6)    20 (8)    19 (10)   10 (6)    Membrane transport
  Translocation protein TolB                                                                                NP_881876   BP3343    tolB    48    P      13 (3)    15 (4)    21 (6)    14 (4)    Transport
  Trifunctional transcriptional regulator/proline DH/P-5-C DH                                               NP_881353   BP2749    putA    140   C      11 (9)    10 (8)    14 (12)   14 (12)   Amino acid metabolism
  Twin argininte translocase protein A                                                                      NP_882278   BP3777    tatA    8     U      35 (2)    35 (2)    35 (2)    35 (2)    Membrane transport
  Type II citrate synthase                                                                                  NP_880994   BP2358    qltA    48    C      11 (3)    8 (2)     10 (3)    10 (3)    Carbohydrate metabolism
  Ubiquinol oxidase polypeptide I                                                                           NP_881514   BP2932    cyoB    72    CM     6 (3)     6 (2)     9 (4)     6 (2)     Energy metabolism
  Uridylate kinase                                                                                          NP_880163   BP1421    pyrH    26    C      13 (3)    10 (2)    23 (4)    16 (3)    Nucleotide metabolism
  Virulence factors transcription regulator                                                                 NP_880570   BP1878    bvgA    23    C      43 (7)    59 (9)    52 (8)    34 (5)    Signal transduction
  DNA polymerase I                                                                                          NP_880026   BP1254    polA    99    C      5 (3)     5 (3)                         Nucleotide metabolism
  Acetyl-CoA synthetase                                                                                     NP_881040   BP2409    acsA    72    C      6 (3)               4 (2)               Carbohydrate metabolism
  2-Oxoglutarate dehydrogenase E1 component[\^](#TFN7){ref-type="table-fn"}                                 NP_879903   BP1124    sucA    106   C      2 (1)               4 (2)               Metabolism
  Probable Orn/Arg/Lys decarboxylase[\^](#TFN7){ref-type="table-fn"}                                        NP_879079   BP0190    U       83    C      3 (1)               4 (2)               Amino acid metabolism
  Autotransporter                                                                                           NP_879378   BP0529    U       246   OM/E   7 (2)     5 (6)               2 (2)     Membrane transport
  Cytochrome B[\^](#TFN7){ref-type="table-fn"}                                                              NP_879156   BP0276    petB    51    CM     17 (5)    3 (1)               5 (2)     Energy metabolism
  DNA mismatch repair protein[\^](#TFN7){ref-type="table-fn"}                                               NP_879129   BP0244    mutL    69    C      4 (2)     6 (2)               5 (1)     DNA processing
  HP BP3084                                                                                                 NP_881655   BP3084    HP      41    C      18 (4)    17 (4)              10 (2)    HP
  Ubiquinol-cytochrome C reductase iron--sulfur subunit                                                     NP_879157   BP0277    petA    23    CM     24 (3)    24 (3)              19 (2)    Energy metabolism
  30s ribosomal protein S20[\^](#TFN7){ref-type="table-fn"}                                                 NP_881377   BP2773    rspT    90    U      14 (2)    13 (1)    14 (2)              Translation
  Putative membrane-bound transglycosylase[\^](#TFN7){ref-type="table-fn"}                                  NP_881812   BP3268    Pu      47    OM     4 (1)               14 (4)    16 (4)    Membrane biogenesis
  Putative transglycosylase[\^](#TFN7){ref-type="table-fn"}                                                 NP_881631   BP3060    Pu      76    P      4 (2)               4 (1)     4 (1)     Membrane biogenesis
  Dermonecrotic toxin                                                                                       NP_881965   BP3439    dnt     161   U                5 (4)     2 (2)     4 (4)     Cell death
  Putative periplasmic solute-binding                                                                       NP_880224   BP1487    smoM    40    U                8 (2)     8 (2)     16 (4)    Putative transport
  Serotype 3 fimbrial subunit                                                                               NP_880302   BP1568    fim3    22    E                20 (3)    27 (4)    15 (2)    Cell integrity
  CTP synthetase (synthase)                                                                                 NP_881022   BP2389    pyrG    61    C      5 (2)                                   Nucleotide metabolism
  Cycolysin secretion protein                                                                               NP_879580   BP0762    cyaD    48    CM     12 (3)                                  Membrane transport
  HP BP1123                                                                                                 NP_879902   BP1123    HP      75    U      11 (5)                                  HP
  Putative ketopantoate reductase                                                                           NP_880110   BP1360    Pu      34    C      10 (2)                                  HP/metabolism
  Putative transcriptional regulation protein                                                               NP_881198   BP2571    Pu      15    U      27 (2)                                  HP/RNA processing
  Serotype 2 fimbrial subunit                                                                               P05788      BP1119    fim2    23    E      21 (2)                                  Cell integrity
  Threonyl-tRNA-synthetase                                                                                  NP_880233   BP1497    thrS    71    C      8 (3)                                   Translation
  ABC transport protein, ATP-binding component                                                              NP_881414   BP2816    metN    40    CM               10 (2)                        Membrane transport
  HP BP3441                                                                                                 NP_881967   BP3441    HP      36    M/U              19 (3)                        HP
  BpH2 (novel histone --- 18323)                                                                            AAB40156    U         bph2    16    U                          19 (2)              DNA processing
  Putative heme receptor                                                                                    NP_879314   BP0456    hemC    82    OM                         6 (3)               Membrane transport
  Trigger factor                                                                                            NP_880485   BP1774    tig     48    U                          8 (2)               Cell division
  Exopolyphosphatase                                                                                        NP_879857   BP1073    ppx     55    C                                    4 (2)     Nucleotide metabolism
  HP BP2486                                                                                                 NP_881113   BP2486    HP      45    CM                                   8 (2)     HP
  HP BP3002                                                                                                 NP_881577   BP3002    HP      69    C                                    6 (2)     HP

Numerical values are based on a greater that 95% Scaffold protein identification probability\*\*.

Abbreviations: T --- Tohama I, C --- C056, D --- D946 and F --- F656.

PSORTb subcellular scores were used to predict and localize the identified EMF proteins.

KEGG identifiers were employed to assign functions to each of the identified EMF proteins.

NCBI Gi accession numbers were used to further compile information such as gene identification number, subcellular localization (PSORTb) and protein function (KEGG identifiers). Values noted represent percent amino acid coverage of the identified EMF protein. (Number of unique peptides detected in parenthesis.).

indicates that identified proteins only had one unique detected tryptic peptide. No numerical value noted indicates that the protein was not identified in the strain.

Abbreviations: T --- Tohama I, C --- C056, D --- D946 and F --- F656; OM --- outer membrane, CM --- cytoplasmic membrane, C --- cytoplasm, P --- periplasm, E --- extracellular, M --- membrane, U --- unknown, Pu --- putative, HP --- hypothetical protein; DH (dehydrogenase), P-5-C-DH (pyrroline-5-carboxylate DH), SFP (superfamily protein), 5-meta (5-methyltetrahydropteroyltriglutamate--homocysteine methyltransferase); BBP --- *B. parapertussis*, BB --- *B. bronchiseptica*, BAV -- *B. avium*.

  A Summary of identified *Bp* putative immunogenic proteins using the mouse model (\*\* --- [Table 2A](#T2){ref-type="table"}).                     
  -------------------------------------------------------------------------------------------------------------------------------- ----- ----- ----- ----
  Total PIPs                                                                                                                       19    31    31    12
  Total PIPs with CR or NS with normal mouse IgG bound-beads                                                                       6     7     12    4
  Total PIPS without CR or NS with normal IgG bound-beads                                                                          13    24    19    8
  \% of total surfaceome (EMF) with tentative antigenic protein potential                                                          11%   18%   18%   7%

  B Putative *Bp* immunogenic proteins identified among *Bp* strains assessed in the study.                                                                                                                                                                
  ------------------------------------------------------------------------------------------- ------------------ ----- ------ ---------------------------------------- ----------------------------------------- ----------------------------------------- ----------------------------------------
  Autotransporter (Vag8)                                                                      [NP_880953]{.ul}   101   OM/E                                            11(6)[\*](#TFN12){ref-type="table-fn"}    16(10)[\*](#TFN12){ref-type="table-fn"}   5(3)
                                                                                                                                                                                                                                                           
  Chaperonin GroEL                                                                            [NP_882014]{.ul}   60    C                                               12(4)                                     14(5)                                     
  Elongation factor Ts                                                                        [CAE33099]{.ul}    34    C                                               19(5)                                                                               
  Elongation factor Tu                                                                        [NP_878925]{.ul}   44    C                                               8(2)                                      15(4)                                     
  F0F1 ATP synthase subunit B[\^](#TFN11){ref-type="table-fn"}                                [NP_881826]{.ul}   17    CM                                                                                        10(1)                                     
  Fructose-1,6-bisphosphate aldolase                                                          [NP_880254]{.ul}   39    C                                               14(4)                                                                               
  Glyceraldehyde-3-phosphate dehydrogenase                                                    [NP_879794]{.ul}   37    C                                               8(2)                                                                                
  HP BB 4955                                                                                  [NP_891489]{.ul}   74    U      6(2)                                                                                                                         
  HP BP 0205                                                                                  [NP_879093]{.ul}   21    U      10(2)                                                                              22(2)[\*](#TFN12){ref-type="table-fn"}    
  HP BP 0455                                                                                  [NP_879313]{.ul}   74    U      3(1)                                                                                                                         
  HP BP 1057                                                                                  [NP_879842]{.ul}   12    U                                                                                         23(2)                                     
                                                                                                                                                                                                                                                           
  HP BP 1440[\^](#TFN11){ref-type="table-fn"}                                                 [NP_880182]{.ul}   34    U      22(4)[\*](#TFN12){ref-type="table-fn"}   12(2)[\*](#TFN12){ref-type="table-fn"}    34(6)[\*](#TFN12){ref-type="table-fn"}    8(1)
                                                                                                                                                                                                                                                           
  HP BP 1485[\^](#TFN11){ref-type="table-fn"}                                                 [NP_880222]{.ul}   58    C                                               3(1)[\*](#TFN12){ref-type="table-fn"}     15(6)[\*](#TFN12){ref-type="table-fn"}    
  HP BP 2191                                                                                  [NP_880839]{.ul}   48    U      7(2)[\*](#TFN12){ref-type="table-fn"}                                              8(2)                                      
  ketol-acid reductoisomerase                                                                 [NP_879606]{.ul}   37    C                                               13(3)                                                                               
  N-acetyl-gamma-glutamyl-phosphate reductase                                                 [NP_881539]{.ul}   39    C                                               16(4)                                                                               
                                                                                                                                                                                                                                                           
  Outer membrane porin protein OmpQ                                                           [NP_881933]{.ul}   40    OM     8(2)                                     8(2)[\*](#TFN12){ref-type="table-fn"}     13(3)[\*](#TFN12){ref-type="table-fn"}    8(2)
                                                                                                                                                                                                                                                           
  Outer membrane porin protein precursor                                                      [NP_879650]{.ul}   42    OM     30(7)[\*](#TFN12){ref-type="table-fn"}   50(13)[\*](#TFN12){ref-type="table-fn"}   35(9)[\*](#TFN12){ref-type="table-fn"}    35(9)[\*](#TFN12){ref-type="table-fn"}
                                                                                                                                                                                                                                                           
  Outer membrane protein A precursor                                                          [NP_879744]{.ul}   21    OM     17(4)[\*](#TFN12){ref-type="table-fn"}   21(5)[\*](#TFN12){ref-type="table-fn"}    17(4)[\*](#TFN12){ref-type="table-fn"}    35(4)[\*](#TFN12){ref-type="table-fn"}
                                                                                                                                                                                                                                                           
  Pertactin[\^](#TFN11){ref-type="table-fn"}                                                  [BAF35031]{.ul}    101   OM     6(3)                                     4(2)                                      2(1)                                      
  Phospho-2-dehydro-3-deoxyheptonate aldolase                                                 [NP_881490]{.ul}   39    C                                               13(3)                                                                               
                                                                                                                                                                                                                                                           
  Preprotein translocase subunit SecD                                                         [NP_879831]{.ul}   69    CM                                              5(2)                                      7(3)[\*](#TFN12){ref-type="table-fn"}     5(2)
                                                                                                                                                                                                                                                           
  Putative bifunctional protein                                                               [NP_882247]{.ul}   43    CM                                                                                        8(2)                                      
  Putative binding-protein-dependent[\^](#TFN11){ref-type="table-fn"}                         [NP_881859]{.ul}   42    P      10(2)                                    12(3)                                     3(1)                                      
  Putative efflux system transmembrane...[\^](#TFN11){ref-type="table-fn"}                    [NP_880739]{.ul}   118   CM     4(2)                                     2(1)                                                                                
  Putative exported solute binding protein                                                    [NP_881542]{.ul}   40    U                                               8(2)                                                                                
  Putative inner membrane protein                                                             [NP_881862]{.ul}   26    U      15(2)                                                                                                                        
  Putative inner membrane protein                                                             [NP_886531]{.ul}   62    CM                                                                                        6(2)                                      
  Putative inner membrane-anchored protein                                                    [NP_880838]{.ul}   33    U      8(2)                                                                               8(2)                                      
  Putative [l]{.smallcaps}-lactate dehydrogenase                                              [NP_879251]{.ul}   39    C                                               11(3)                                                                               
                                                                                                                                                                                                                                                           
  Putative lipoprotein                                                                        [NP_881568]{.ul}   18    OM     44(4)                                    14(2)                                     49(5)[\*](#TFN12){ref-type="table-fn"}    35(3)[\*](#TFN12){ref-type="table-fn"}
                                                                                                                                                                                                                                                           
  Putative lipoprotein                                                                        [NP_880303]{.ul}   41    U                                               12(3)                                                                               
  Putative outer membrane ligand binding protein                                              [NP_879893]{.ul}   144   OM     4(3)                                                                                                                         
  Putative peptidase                                                                          [NP_880436]{.ul}   32    OM                                                                                        16(2)                                     
                                                                                                                                                                                                                                                           
  Putative peptidoglycan-associated lipoprotein[\^](#TFN11){ref-type="table-fn"}              [NP_881875]{.ul}   18    OM                                              17(2)                                     29(3)[\*](#TFN12){ref-type="table-fn"}    7(1)
                                                                                                                                                                                                                                                           
  Putative periplasmic solute-binding protein                                                 [NP_880224]{.ul}   40    U                                               15(4)                                                                               
  Putative secreted protein[\^](#TFN11){ref-type="table-fn"}                                  [NP_879832]{.ul}   13    U                                               21(1)                                     32(2)                                     
  Putative sulfatase                                                                          [NP_881701]{.ul}   72    CM                                                                                        4(2)                                      
  Probable inner-membrane protein                                                             [CAE35357]{.ul}    61    CM                                                                                        6(2)                                      
  Rod-shape determining protein                                                               [NP_879246]{.ul}   38    C                                               16(4)                                                                               
                                                                                                                                                                                                                                                           
  SCO1/SenC family protein[\^](#TFN11){ref-type="table-fn"}                                   [NP_88223]{.ul}7   22    U                                               6(1)                                      6(1)                                      6(1)
                                                                                                                                                                                                                                                           
  Serotype 3 fimbrial subunit                                                                 [NP_88030]{.ul}2   22    E                                                                                         17(2)                                     
                                                                                                                                                                                                                                                           
  Serum resistance protein (BrkA)                                                             [NP_88201]{.ul}3   111   OM     4(3)[\*](#TFN12){ref-type="table-fn"}    3(2)                                      4(3)                                      4(3)
                                                                                                                                                                                                                                                           
  Signal peptidase I                                                                          [NP_88106]{.ul}0   32    CM                                                                                        7(2)                                      
  Surface antigen                                                                             [NP_88016]{.ul}9   86    OM     6(3)                                                                                                                         
                                                                                                                                                                                                                                                           
  Thiol:disulfide interchange protein                                                         [NP_88215]{.ul}4   71    CM                                              3(2)                                      3(2)[\*](#TFN12){ref-type="table-fn"}     3(2)
                                                                                                                                                                                                                                                           
  TonB-dependent receptor for iron transport                                                  [NP_87966]{.ul}6   82    OM     4(2)                                     5(3)                                      13(7)                                     
                                                                                                                                                                                                                                                           
  Tracheal colonization factor precursor                                                      [NP_87997]{.ul}4   71    OM     6(3)[\*](#TFN12){ref-type="table-fn"}    7(3)[\*](#TFN12){ref-type="table-fn"}     7(3)[\*](#TFN12){ref-type="table-fn"}     9(4)[\*](#TFN12){ref-type="table-fn"}

Abbreviations: T --- Tohama I, C --- C056, D --- D946 and F --- F656; CR --- cross-reactivity, NS --- non-specificity, IgG --- immunoglobulin G, EMF --- enriched membrane fraction, PIPs --- putative immunogenic proteins.

Values noted represent percent amino acid coverage of the identified IP protein using the mouse model. (Number of unique peptides detected in parenthesis.). No numerical value noted indicates that the protein was not identified in the mouse IP.

indicates that identified proteins only had one unique detected tryptic peptide.

Asterisk (\*) indicates that the protein identified in the mouse IP was cross-reactive with normal mouse IgG-bound beads. Blue-shaded box: common in all 3 clinical isolates; black-bordered box: common in all 4 strains.

Abbreviations: T --- Tohama I, C --- C056, D --- D946 and F --- F656; OM --- outermembrane, CM --- cytoplasmic membrane, C --- cytoplasm, P --- periplasm, E --- extracellular, M --- membrane, U --- unknown, HP --- hypothetical protein, BB --- *B. bronchiseptica*.

  **A** Summary of identified *Bp* putative immunogenic proteins using the human model (\*\* --- [Table 2A](#T2){ref-type="table"}).                  
  ------------------------------------------------------------------------------------------------------------------------------------ ---- ---- ---- ----
  Total PIPs                                                                                                                           4    12   8    10
  Total PIPs with CR or NS with normal mouse IgG bound-beads                                                                           3    9    8    7
  Total PIPS without CR or NS with normal IgG bound-beads                                                                              1    3    0    3
  \% of total surfaceome (EMF) with tentative antigenic protein potential                                                              1%   2%   0%   2%

  **B** Putative *Bp* immunogenic proteins identified among *Bp* strains assessed in the study.                                                                                                                                                  
  ----------------------------------------------------------------------------------------------- ------------------ ---------------------------------------- ---------------------------------------- ----------------------------------------- ----------------------------------------
  Autotransporter (Vag8)                                                                          [NP_880953]{.ul}                                            12(8)[\*](#TFN17){ref-type="table-fn"}   17(12)[\*](#TFN17){ref-type="table-fn"}   7(4)[\*](#TFN17){ref-type="table-fn"}
                                                                                                                                                                                                                                                 
  HP BP 0205[\^](#TFN16){ref-type="table-fn"}                                                     [NP_879093]{.ul}                                            6(1)[\*](#TFN17){ref-type="table-fn"}                                              21(4)
  HP BP 1440                                                                                      [NP_880182]{.ul}   10(3)                                                                             27(5)[\*](#TFN17){ref-type="table-fn"}    11(3)
  HP BP 1485                                                                                      [NP_880222]{.ul}                                            9(3)[\*](#TFN17){ref-type="table-fn"}    16(7)[\*](#TFN17){ref-type="table-fn"}    6(2)
  HP BP 3689                                                                                      [NP_882194]{.ul}                                                                                                                               18(2)
                                                                                                                                                                                                                                                 
  Outer membrane porin protein OmpQ[\^](#TFN16){ref-type="table-fn"}                              [NP_881933]{.ul}   3(1)[\*](#TFN17){ref-type="table-fn"}    7(2)[\*](#TFN17){ref-type="table-fn"}    11(3)[\*](#TFN17){ref-type="table-fn"}    4(1)[\*](#TFN17){ref-type="table-fn"}
                                                                                                                                                                                                                                                 
  Outer membrane porin protein precursor                                                          [NP_879650]{.ul}   23(6)[\*](#TFN17){ref-type="table-fn"}   21(7)[\*](#TFN17){ref-type="table-fn"}                                             
                                                                                                                                                                                                                                                 
  Outer membrane protein A precursor                                                              [NP_879744]{.ul}   10(3)[\*](#TFN17){ref-type="table-fn"}   21(5)[\*](#TFN17){ref-type="table-fn"}   21(5)[\*](#TFN17){ref-type="table-fn"}    17(3)[\*](#TFN17){ref-type="table-fn"}
                                                                                                                                                                                                                                                 
  Preprotein translocase subunit SecD                                                             [NP_879831]{.ul}                                                                                     12(5)[\*](#TFN17){ref-type="table-fn"}    
  Probable inner membrane protein                                                                 [CAE35357]{.ul}                                             4(2)[\*](#TFN17){ref-type="table-fn"}                                              
  Putative lipoprotein                                                                            [NP_881568]{.ul}                                            37(3)[\*](#TFN17){ref-type="table-fn"}                                             22(2)[\*](#TFN17){ref-type="table-fn"}
  Serum resistance protein (BrkA)                                                                 [NP_882013]{.ul}                                            2(2)[\*](#TFN17){ref-type="table-fn"}                                              
  Thiol:disulfide interchange protein                                                             [NP_882154]{.ul}                                            3(2)                                                                               
  TonB-dependent receptor for iron transport                                                      [NP_879666]{.ul}                                            7(4)                                     19(11)[\*](#TFN17){ref-type="table-fn"}   3(2)
  Tracheal colonization factor protein                                                            [NP_879974]{.ul}                                            9(4)[\*](#TFN17){ref-type="table-fn"}    10(5)[\*](#TFN17){ref-type="table-fn"}    7(3)[\*](#TFN17){ref-type="table-fn"}

Abbreviations: T --- Tohama I, C --- C056, D --- D946 and F --- F656; CR --- cross-reactivity; NS --- non-specificity; IgG --- immunoglobulin G; EMF --- enriched membrane fraction; PIPs --- putative immunogenic protein.

Values noted represent percent amino acid coverage of the identified IP protein using the human model. (Number of unique peptides detected in parenthesis.). No numerical value noted indicates that the protein was not identified in the human IP.

indicates that identified proteins only had one unique detected tryptic peptide.

Asterisk (\*) indicates that the protein identified in the human IP was cross-reactive with normal human IgG-bound beads. Pink-shaded box --- protein identified in human and mouse IP; yellow-shaded box --- strain-specific protein identification only in human IP; black-bordered box: common in all 4 strains.

Abbreviation: T --- Tohama I, C --- C056, D --- D946 and F --- F656.
